Serina Therapeutics Inc (SER)
USD 6.13
(27.98%)
USD 6.13
(27.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 142 Thousand | 500 Thousand | 3.03 Million | 54 Thousand | 1.72 Million | 1.39 Million |
| Cost of Revenue | 171 Thousand | 145 Thousand | 150 Thousand | 1.28 Million | 998.5 Thousand | 841 Thousand |
| Gross Profit | -29 Thousand | 355 Thousand | 2.88 Million | -1.22 Million | 729.5 Thousand | 555 Thousand |
| Operating Expenses | 9.93 Million | 2.77 Million | 4.67 Million | 9.18 Million | 13.28 Million | 11 Million |
| Selling, General and Administrative Expenses | 9.32 Million | 1.28 Million | 1.29 Million | 5.59 Million | 7.94 Million | 5.64 Million |
| Research and Development Expenses | 603 Thousand | 1.57 Million | 3.79 Million | 3.58 Million | 5.34 Million | 5.35 Million |
| Other Expenses | - | -265.91 Thousand | - | - | - | - |
| Cost and Expenses | 10.1 Million | 2.77 Million | 4.67 Million | 10.46 Million | 14.28 Million | 11.84 Million |
| Operating Income | -9.96 Million | -2.27 Million | -1.63 Million | -10.4 Million | -12.55 Million | -10.44 Million |
| Interest Expense | 4.9 Million | 15.87 Thousand | 3094.00 | 404 Thousand | - | - |
| Income Tax Expense | -8000.00 | -250.03 Thousand | 3094.00 | 466 Thousand | 148 Thousand | -229 Thousand |
| Earnings before Tax | -14.81 Million | -2.68 Million | -1.26 Million | -10.39 Million | -12.23 Million | -7.73 Million |
| Net Income | -14.8 Million | -2.68 Million | -1.26 Million | -10.86 Million | -12.15 Million | -7.5 Million |
| Earnings Per Share Basic | -13.72 | -2.49 | -1.17 | -10.14 | -11.47 | -7.56 |
| Earnings Per Share Diluted | -13.72 | -2.49 | -1.17 | -10.14 | -11.47 | -7.56 |
| Weighted Average Shares Outstanding | 1.07 Million | 1.07 Million | 1.07 Million | 1.07 Million | 1.05 Million | 992.72 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.07 Million | 1.07 Million | 1.07 Million | 1.07 Million | 1.05 Million | 992.72 Thousand |
| Gross Margin | -0.20 | 0.71 | 0.95 | -22.72 | 0.42 | 0.40 |
| EBIT Margin | -68.87 | -4.95 | -0.52 | -169.48 | -6.72 | -7.10 |
| Profit Margin | -104.25 | -5.36 | -0.42 | -201.20 | -7.03 | -5.37 |
| EBITDA | -9.78 Million | -2.6 Million | -1.58 Million | -8.74 Million | -11.6 Million | -7.19 Million |
| Earnings Before Tax Margin | -70.14 | -4.54 | -0.54 | -192.72 | -7.27 | -7.48 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 51 Thousand | 5000.00 | 142 Thousand | 56 Thousand | 67 Thousand | 9000.00 |
| Cost of Revenue | 57 Thousand | 25 Thousand | 171 Thousand | 34 Thousand | 66 Thousand | 37 Thousand |
| Gross Profit | -6000.00 | -20 Thousand | -29 Thousand | 22 Thousand | 1000.00 | -28 Thousand |
| Operating Expenses | 3.86 Million | 2.32 Million | 9.93 Million | 3.58 Million | 2.35 Million | 1.85 Million |
| Selling, General and Administrative Expenses | 2.32 Million | 1.22 Million | - | 3.43 Million | 2.17 Million | 1.73 Million |
| Research and Development Expenses | 1.53 Million | 1.1 Million | - | 149 Thousand | 185 Thousand | 128 Thousand |
| Other Expenses | -9000.00 | - | - | - | - | - |
| Cost and Expenses | 3.91 Million | 2.32 Million | 10.1 Million | 3.61 Million | 2.42 Million | 1.89 Million |
| Operating Income | -3.86 Million | -2.32 Million | -9.96 Million | -3.56 Million | -2.35 Million | -1.88 Million |
| Interest Expense | 242 Thousand | 99 Thousand | 4.9 Million | - | 3.03 Million | 195.7 Thousand |
| Income Tax Expense | -27 Thousand | 99 Thousand | -8000.00 | -2000.00 | 12 Thousand | -10 Thousand |
| Earnings before Tax | 5.17 Million | -9.43 Million | -14.81 Million | -3.45 Million | -5.38 Million | -2.67 Million |
| Net Income | 5.2 Million | -9.43 Million | -14.8 Million | -3.45 Million | -5.4 Million | -2.66 Million |
| Earnings Per Share Basic | 0.61 | -3.38 | - | -3.20 | -5.01 | -2.47 |
| Earnings Per Share Diluted | 0.51 | -3.38 | - | -3.20 | -5.01 | -2.47 |
| Weighted Average Shares Outstanding | 8.51 Million | 2.79 Million | 1.07 Million | 1.07 Million | 1.07 Million | 1.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.15 Million | 2.79 Million | 1.07 Million | 1.07 Million | 1.07 Million | 1.07 Million |
| Gross Margin | -0.12 | -4.00 | -0.20 | 0.39 | 0.01 | -3.11 |
| EBIT Margin | -74.69 | -459.20 | - | -62.98 | -34.67 | -206.00 |
| Profit Margin | 102.04 | -1887.40 | -104.25 | -61.71 | -80.61 | -296.56 |
| EBITDA | -3.8 Million | -2.29 Million | - | -3.52 Million | -2.32 Million | -1.85 Million |
| Earnings Before Tax Margin | -75.80 | -464.20 | -70.14 | -63.57 | -35.16 | -209.56 |
ZENSARTECH
INKP
NCNC
JCGI
RVMD
UMI